ArticleThe Milbank quarterly2006
A history of drug advertising: the evolving roles of consumers and consumer protection.
Article in The Milbank quarterly, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
35 citing papers in PubMed.
- Review
- Warning Labels as a Public Health Intervention: Effects and Challenges for Tobacco, Cannabis, and Opioid Medications.Annual review of public health · 2024Review
- Acetaminophen causes neurodevelopmental injury in susceptible babies and children: no valid rationale for controversy.Clinical and experimental pediatrics · 2024Article
- Web-Based Information on Spinal Cord Stimulation: Qualitative Assessment of Publicly Accessible Online Resources.JMIR public health and surveillance · 2024Article
- The impact of characteristic factors of the direct-to-consumer marketing model on consumer loyalty in the digital intermediary era.Frontiers in psychology · 2024Article
- ["If you are a woman, read this, it's good for you": the advertising of medicines targeted at mothers in the Colombian press, 1903-1945].Historia, ciencias, saude--Manguinhos · 2024Article
- The Dangers of Acetaminophen for Neurodevelopment Outweigh Scant Evidence for Long-Term Benefits.Children (Basel, Switzerland) · 2023Review
- The commercialisation of insulin.Anaesthesia and intensive care · 2023Article
- Pharmaceutical Advertising and the Subtle Subversion of Patient Autonomy.The Journal of medical humanities · 2022Article
- Influence of Pharmaceutical Direct-to-Consumer Advertisement on Medical Treatment of Inflammatory Bowel Disease-An Outpatient Survey-Based Study.Crohn's & colitis 360 · 2020Article
- Impact of direct-to-consumer drug advertising during the Super Bowl on drug utilization.Research in social & administrative pharmacy : RSAP · 2020Article
- The Impact of Direct-to-Consumer Pharmaceutical Advertising on Public Knowledge of Gastroesophageal Reflux Disease: A Study on Over-the-Counter Proton Pump Inhibitors.Patient preference and adherence · 2020Article
- Rational Use of Medicine in Children-The Conflict of Interests Story. A Review.Rambam Maimonides medical journal · 2019Review
- Pediatric melanoma-The whole (conflicts of interest) story.International journal of women's dermatology · 2019Review
- The Challenges of Pediatric Drug Development.Current therapeutic research, clinical and experimental · 2019Review
- Questionable Industry-Sponsored Postneonatal Pediatric Studies in Slovenia.Current therapeutic research, clinical and experimental · 2019Article
- Are Regulatory Age Limits in Pediatric Melanoma Justified?Current therapeutic research, clinical and experimental · 2019Article
- Direct-to-Consumer Broadcast Advertisements for Pharmaceuticals: Off-Label Promotion and Adherence to FDA Guidelines.Journal of general internal medicine · 2018Article
- Pediatric Melanoma and Drug Development.Children (Basel, Switzerland) · 2018Article
- Do Paediatric Investigation Plans (PIPs) Advance Paediatric Healthcare?Paediatric drugs · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Direct-to-consumer advertising (DTCA) of prescription drugs in the United States is controversial. Underlying the debate are disagreements over the role of consumers in medical decision making, the appropriateness of consumers engaging in self-diagnosis, and the ethics of an industry promoting potentially dangerous drugs. Drug advertising and federal policy governing drug advertising have both responded to and reinforced changes in the consumer's role in health care and in the doctor-patient relationship over time. This article discusses the history of DTCA in the context of social movements to secure rights for health care patients and consumers, the modern trend toward consumer-oriented medicine, and the implications of DTCA and consumer-oriented medicine for contemporary health policy debates about improving the health care system.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.